|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.88 EUR | -0.35% |
|
-2.37% | -21.53% |
| Mar. 26 | Atrys Health, S.A. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| 2023 | Atrys Health, S.A. announced that it has received ?13.3 million in funding | CI |
Atrys Health, S.A. reported earnings results for the half year ended June 30, 2022. For the half year, the company reported sales was EUR 92.4 million compared to EUR 43.07 million a year ago. Revenue was EUR 92.94 million compared to EUR 43.41 million a year ago.
Net loss was EUR 3.17 million compared to EUR 3.73 million a year ago. Basic loss per share was EUR 0.05 compared to EUR 0.09 a year ago. Diluted loss per share was EUR 0.05 compared to EUR 0.09 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -21.53% | 233M | |
| -14.92% | 84.68B | |
| +13.30% | 81.12B | |
| +11.62% | 29.4B | |
| -12.71% | 16.73B | |
| -3.06% | 16.36B | |
| -2.63% | 14.92B | |
| -31.75% | 11.77B | |
| -1.42% | 11.72B | |
| +27.44% | 11.71B |
ATRYS HEALTH, S.A. 
